US seeks injunction against Ranbaxy

8220;Our commitment to ensuring that the drugs the American people rely on are safe,effective and manufactured according to the FDA8217;s standards extends beyond our borders,8221; West said.

The consent decree filed is unprecedented in its scope,and requires Ranbaxy to take a wide range of actions to correct its violations and ensure that they do not happen again,said the Justice Department.

Among other things,the consent decree seeks to prevent Ranbaxy from manufacturing drugs for the US market at certain of its facilities until those facilities can do so according to US standards.

Once the settlement is approved by the court,it becomes a court order with which Ranbaxy must comply or face contempt.

In a statement,Ranbaxy said that under the terms of the consent decree,which it signed on December 20 last year,the pharma company has committed to further strengthen procedures and policies to ensure data integrity and to comply with current good manufacturing practices.